JMP Securities Upgrades Anadys Pharmaceuticals (ANDS) to Market Outperform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/11/2026

1. COO
2. ORCL
3. ADBE
4. CHWY
5. NVDA
6. AVAV
7. RH
8. SPY
9. MSFT
10. AAPL

October 4, 2011 8:05 AM EDT
Get Alerts ANDS Hot Sheet
Price: $3.70 --0%

Rating Summary:
    0 Buy, 6 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 1 | Down: 3 | New: 32
Join SI Premium – FREE
JMP Securities upgraded Anadys Pharmaceuticals (NASDAQ: ANDS) from Market Perform to Market Outperform with a new price target of $3.00.

For more ratings news on Anadys Pharmaceuticals click here and for the rating history of Anadys Pharmaceuticals click here.

Shares of Anadys Pharmaceuticals closed at $0.82 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Upgrades

Related Entities

JMP Securities